Yamagata J, Agishi T, Ota K, Shida K, Shibayama K, Yamanaka E, Hata H, Nagata T, Ishigami J, Kamidono S
Gan To Kagaku Ryoho. 1983 Oct;10(10):2139-44.
Nineteen patients with malignant tumors were treated with a combination of bolus administration of mitomycin C with direct hemoperfusion over charcoal, and 15 patients were valuable. Mitomycin C of 1 mg/kg was administered via a catheter placed into the regional artery. Seven out of 14 patients with genitourinary cancers: 4 out of 9 patients with urinary bladder, 2 of 4 patients with renal and one prostate responded to the therapy. There were 4 responders out of 8 in the one-shot administration group, on the other hand, 7 cases receiving continuous infusion of 60 to 120 minutes responded. In both the one-shot group and the continuous group nausea and vomiting were observed in 21% and 11% respectively. Three patients receiving continuous administration of mitomycin C had local ulcerations. Myelosuppressions such as leukocytopenia and thrombocytopenia were observed in 37% of the both groups.
19例恶性肿瘤患者接受了丝裂霉素C大剂量注射联合活性炭直接血液灌注治疗,其中15例患者疗效显著。通过置于局部动脉的导管给予1mg/kg的丝裂霉素C。14例泌尿生殖系统癌症患者中有7例有反应:9例膀胱癌患者中有4例、4例肾癌患者中有2例以及1例前列腺癌患者有反应。单次给药组8例中有4例有反应,另一方面,持续输注60至120分钟的7例有反应。单次给药组和持续给药组分别有21%和11%的患者出现恶心和呕吐。3例接受丝裂霉素C持续给药的患者出现局部溃疡。两组均有37%的患者出现白细胞减少和血小板减少等骨髓抑制。